皮维尔-2代表了默克尔细胞癌的不良预测因子,它调节蛋白,细胞循环停止和SOX-2表达
Stefan Janik1, Johannes Pammer2, Elisabeth Simader3
1Department of Otolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna, Austria.
Scientific reports
|November 10, 2025
概括
高Piwil-2表达表明默克尔细胞癌 (MCC) 的预后不佳,这是一种罕见的皮肤癌. 这一发现将Piwil-2与MCC开发和SOX-2联系起来,SOX-2是一个关键的调节器.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 病毒学 病毒学
背景情况:
- 默克尔细胞癌 (MCC) 是一种罕见的,具有高复发率的侵袭性皮肤癌.
- MCC通常与默克尔细胞多细胞瘤病毒 (MCPyV) 感染有关,通常影响头部和部.
- 皮维尔-2和PIWI相互作用RNAs (piRNAs) 与各种固体瘤有关.
研究的目的:
- 调查Piwil-2表达在MCC中的作用.
- 为了将Piwil-2水平与临床结果和MCPyV状态相关联.
- 探索Piwil-2在MCC细胞中的分子效应.
主要方法:
- 在27个MCC标本中分析了Piwil-2表达.
- 在Piwil-2表达,瘤阶段,MCPyV状态和患者结果之间进行了相关性分析.
- 使用MCC细胞系中的siRNAs进行Piwil-2的下调,以评估对piRNA,蛋白质,细胞周期和SOX-2表达的下游影响.
主要成果:
- 高Piwil-2表达与晚期瘤阶段,MCPyV阳性和较差的患者结果有关.
- 皮维尔-2敲除显著改变了202个piRNA和419个蛋白质,包括对病毒驱动的MCC通路蛋白的下调 (TRRAP,BRD8,PRIM2,ORC4).
- 皮维尔-2的下调诱导了中度的G0/G1细胞循环停止和上调的SOX-2,这是默克尔细胞的关键调节者.
结论:
- 在MCC中,Piwil-2作为一个不良的预后标志物.
- 皮维尔-2表达与MCC瘤发生和SOX-2调节有关.
- 需要进一步的研究来阐明这些发现的机制和临床相关性.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K


